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or another unknown lyssavirus. These 
findings are similar to findings report-
ed from other parts of Asia (3–5).
Information on lyssavirus circu-
lation in bat populations in Vietnam 
should be made available to public 
health authorities, clinicians, and the 
general public to increase awareness 
of the risk for rabies transmission from 
bats; improve recognition, documenta-
tion, and reporting of bat exposure to ra-
bies surveillance systems; and increase 
consideration of the need for post ex-
posure prophylaxis after receiving a 
bat bite. Our data suggest that several 
lyssaviruses are circulating among bats 
in northern Vietnam, and a substantial 
proportion have neutralizing antibod-
ies to RABV. Further investigations are 
required, particularly of sick and dying 
bats, to determine the implications of 
these findings for human health.
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Co-Production of 
NDM-1 and OXA-232 
by Klebsiella  
pneumoniae
To the Editor: New Delhi 
metallo-β-lactamase 1 (NDM-1) and 
OXA-48-group β-lactamase have 
been increasingly reported as car-
bapenemases responsible for carbape-
nem resistance in Enterobacteriaceae 
worldwide (1). However, in the Unit-
ed States, Klebsiella pneumoniae car-
bapenemase (KPC)–type β-lactamase 
is the most common carbapenemase 
among Enterobacteriaceae, especial-
ly K.  pneumoniae. Isolates produc-
ing NDM-1 were first reported in the 
United States in 2010 (2), followed 
by several case reports and most re-
cently a hospital outbreak in Colo-
rado (3–6). As for OXA-48-group 
β-lactamase, 2 cases of infection with 
OXA-48–producing K. pneumoniae 
were recently reported from Virginia 
(7). We report K. pneumoniae co-pro-
ducing NDM-1 and OXA-232, a vari-
ant of OXA-48, and Escherichia coli 
producing NDM-1 that were isolated 
from the same patient.
A 69-year-old woman was hos-
pitalized in India for subarachnoid 
hemorrhage in January 2013. Her 
hospitalization was complicated by 
unsuccessful coil embolization and 
subsequent hydrocephalus. A ventric-
uloperitoneal shunt was inserted, and 
she was transferred to an acute care 
hospital in Pittsburgh, Pennsylvania, 
USA, for further management in Feb-
ruary 2013. She underwent reinsertion 
of the shunt and was discharged to a 
long-term care facility (LTCF 1). She 
was readmitted to the same hospital 
because of fever in March 2013.
A urine culture collected at the 
time of readmission grew carbapenem-
resistant K. pneumoniae and extend-
ed-spectrum β-lactamase–producing 
E. coli. Although production of KPC-
type β-lactamase was initially suspect-
ed in K. pneumoniae, the unusually 
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high level of resistance to amikacin 
(MIC >32 μg/mL) and gentamicin 
(MIC >8 μg/mL) increased concern 
for presence of an NDM-1 producer, 
which is frequently highly resistant to 
aminoglycosides because of produc-
tion of 16S rRNA methyltransferase 
(8). A modified Hodge test showed a 
positive result for carbapenemase pro-
duction, and a metallo-β-lactamase 
Etest (bioMérieux, Marcy l’Etoile, 
France) showed a positive result for 
metallo-β-lactamase production.
PCR and sequencing identified 
NDM-1 and OXA-232, a 5-aa vari-
ant of OXA-48 recently reported in K. 
pneumoniae isolates from India (9). 
Presence of the gene for 16S rRNA 
methyltransferase (armA) was also 
confirmed by PCR and sequencing 
and accounted for the high-level ami-
noglycoside resistance. The isolate 
belonged to sequence type (ST) 14, 
as determined by multilocus sequence 
typing, and has been reported to be 
common among NDM-1–producing 
K. pneumoniae in Europe (10).
The patient was discharged to 
LTCF 1 but was readmitted because 
of recurrent fever. A urine culture 
collected at this admission grew car-
bapenem-resistant K. pneumoniae and 
carbapenem-resistant E. coli. This E. 
coli isolate belonged to ST95 and was 
positive for the NDM-1 gene but nega-
tive for the OXA-48 group and armA 
genes. The original extended-spectrum 
β-lactamase–producing E. coli isolate 
belonged to ST3865, which is distinct 
from ST95. Therefore, it is likely that 
the patient was already colonized by 
NDM-1–producing E. coli ST95 at the 
time of the first admission, but this col-
onization was not detected in a clinical 
culture at that time. All K. pneumoniae 
and E. coli isolates remained suscep-
tible to fosfomycin and colistin.
The patient did not receive any 
antimicrobial drug therapy specific for 
these isolates because she was deemed 
to be only colonized with them in the 
urine. Enhanced contact precautions 
were also implemented at the time of 
PCR confirmation of the NDM-1 gene. 
These precautions included all com-
ponents of contact precautions (hand-
washing, gowns, gloves, disinfected/
dedicated equipment), and dedicated 
personnel monitored compliance with 
these measures around the clock.
The patient was eventually dis-
charged to another long-term care fa-
cility (LTCF 2) in April 2013. A point 
surveillance testing for NDM-1–pro-
ducing Enterobacteriaceae by using 
rectal swab specimens was conducted 
for all inpatients at the acute-care hos-
pital and for all residents of the unit at 
LTCF 2. Testing did not identify any 
other patients colonized with NDM-
1–producing Enterobacteriaceae.
In transformation and conjuga-
tion experiments, transformants carry-
ing the OXA-232 gene were obtained 
from K. pneumoniae, but those car-
rying the NDM-1 gene could not be 
obtained by either method, suggesting 
that the 2 genes were not located on 
the same plasmid. For E. coli, trans-
formants and transconjugants carry-
ing the NDM-1 gene were obtained, 
which indicated that this gene was 
located on a self-conjugative plasmid.
Detection of NDM-1– or OXA-48-
group–producing Enterobacteriaceae, 
in particular K. pneumoniae, poses a di-
agnostic challenge in regions to which 
KPC-producing K. pneumoniae is en-
demic. In our case, recognition of resis-
tance to multiple aminoglycosides by an 
automated instrument, which was con-
firmed to be high level by the disk dif-
fusion method (i.e., no inhibition zone), 
prompted early detection and implemen-
tation of appropriate infection preven-
tion measures. Production of 16S rRNA 
methyltransferase by KPC-producing 
K. pneumoniae is extremely rare, and no 
cases have been identified in the United 
States. Therefore, we propose that high-
level resistance to amikacin and genta-
micin can serve as a clue for suspecting 




emase, including variants such as OXA-
232, do not have characteristic suscep-
tibility patterns and may easily not be 
recognized in areas with a high back-
ground prevalence of KPC-producing 
organisms. Therefore, organisms pro-
ducing OXA-48 or their variants might 
have already spread in the United States.
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To the Editor: Shiga toxin–pro-
ducing Escherichia coli (STEC) cause 
severe illness in humans, especially 
young and elderly persons. In previ-
ous decades, prevention and control 
measures focused on STEC O157:H7; 
however, in recent years, non-O157 
STEC–related outbreaks and illnesses 
have been detected more frequently. In 
the United States, 6 serogroups (O26, 
O45, O103, O111, O121, and O145) 
account for ≈75% of the reported non-
O157 STEC illnesses (1).
On August 4, 2010, the Maine 
Center for Disease Control and Pre-
vention (Maine CDC) investigated 2 
isolates of nonmotile STEC O26 that 
were indistinguishable by pulsed-field 
gel electrophoresis (PFGE). Both 
case-patients had diarrhea and ab-
dominal cramps, shopped at grocery 
stores in the same town, and reported 
consumption of ground beef. Case-pa-
tient 1 purchased ground beef at Store 
A; a shopper card used for the pur-
chase was shared with investigators. 
Case-patient 2 consumed ground beef 
purchased from 2 stores (Stores B and 
C); neither shopper cards nor receipts 
were available.
On August 5, a Maine Depart-
ment of Agriculture, Food and Rural 
Resources (Maine DoA) inspector 
visited Stores A and B. On June 25, 
case-patient 1 had purchased 90% 
lean ground beef at Store A; the beef 
was produced by a parent company 
with multiple establishments. Inspec-
tors cross-referenced this purchase 
with meat grinding logs from Store 
B, which revealed that the parent 
company that supplied ground beef to 
Store A also supplied beef to Store B. 
Maine DoA notified the United States 
Department of Agriculture, Food 
Safety and Inspection Service (USDA-
FSIS), of a common manufacturer.
On August 9, the New York State 
(NYS) Department of Health contact-
ed Maine CDC regarding a third case-
patient with an STEC O26 isolate that 
was indistinguishable by PFGE from 
the other 2 isolates. Case-patient 3 
had handled 90% lean ground beef 
purchased from the grocery store 
chain used by case-patient 1 (Store A). 
Shopper card information indicated 
that the beef was purchased on June 
17. Ground beef was the only common 
exposure among the 3 case-patients.
During August 18–26, Maine 
DoA, NYS Department of Agricul-
ture and Markets, and USDA-FSIS 
conducted a traceback of ground beef 
(Figure). Traceback revealed that for 
>10 years, Store A had been purchas-
ing 90% lean ground beef from Estab-
lishment X (1 of many establishments 
within the parent company). Further 
investigation revealed that implicated 
ground beef from Store A locations 
in Maine and New York had come 
from the same lot at Establishment X. 
USDA-FSIS conducted ground beef 
traceback at Stores B and C; source 
materials were received from multiple 
establishments, but Establishment X 
was the only common supplier (Fig-
ure). On August 28, Establishment X 
recalled ≈8,500 pounds of ground beef 
that had been produced on June 11.
On September 2, the NYS De-
partment of Health Public Health 
Laboratory tested leftover hamburger 
patties purchased by case-patient 3. 
The samples were confirmed as STEC 
O26 with a PFGE pattern indistin-
guishable from the strains isolated 
from case-patients.
On November 17, USDA-FSIS 
completed an assessment at Establish-
ment X and determined that the com-
pany’s food safety system was ade-
quate to control pathogens of concern. 
Follow-up testing of beef trim samples 
at Establishment X were negative for 
STEC O26 and O157:H7.
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